LCTX vs AAPL: Which Stock is Better?
Side-by-side comparison of Lineage Cell Therapeutics Inc and Apple Inc in 2026
LCTX
Lineage Cell Therapeutics Inc
$1.71
AAPL
Apple Inc
$270.52
Key Metrics Comparison
| Metric | LCTX | AAPL | Winner |
|---|---|---|---|
| Market Cap | $408.50M | N/A | LCTX |
| P/E Ratio | N/A | 33.32 | AAPL |
| EPS (TTM) | $N/A | $8.11 | AAPL |
| Revenue Growth | 1.3% | 0.2% | LCTX |
| Gross Margin | -22.8% | 47.3% | AAPL |
Analyze LCTX
Full quant analysis
Analyze AAPL
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is LCTX or AAPL a better investment?
Comparing LCTX and AAPL: Lineage Cell Therapeutics Inc has a market cap of $408.50M while Apple Inc has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between LCTX and AAPL?
LCTX (Lineage Cell Therapeutics Inc) and AAPL (Apple Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: LCTX or AAPL?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: LCTX or AAPL?
LCTX has higher revenue growth at 1.3% vs 0.2% for AAPL.
Which company is more profitable: LCTX or AAPL?
Apple Inc (AAPL) has higher gross margins at 47.3% compared to -22.8% for LCTX.
Which is the larger company: LCTX or AAPL?
Lineage Cell Therapeutics Inc (LCTX) is larger with a market cap of $408.50M compared to N/A for AAPL.
Should I buy LCTX or AAPL in 2026?
Both LCTX and AAPL have investment merit. LCTX trades at $1.71 while AAPL trades at $270.52. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between LCTX and AAPL stock?
Key differences: Market Cap ($408.50M vs N/A), P/E Ratio (N/A vs 33.3x), Revenue Growth (1.3% vs 0.2%), Gross Margin (-22.8% vs 47.3%).